Substituted chiral fused [1,2] imidazo [4,5-C] ring compounds and methods
    5.
    发明申请
    Substituted chiral fused [1,2] imidazo [4,5-C] ring compounds and methods 失效
    取代的手性稠合[1,2]咪唑并[4,5-C]环化合物和方法

    公开(公告)号:US20080070907A1

    公开(公告)日:2008-03-20

    申请号:US11827648

    申请日:2007-07-12

    CPC分类号: C07D498/14

    摘要: Substituted fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines, and imidazo[4,5-c]pyridines) with a —CH(—R2)— group in the fused ring at the 2-position of the imidazo ring and a —CH(—R1)— group in the fused ring at the 1-position of the imidazo ring, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

    摘要翻译: 取代的稠合[1,2]咪唑并[4,5-c]环化合物(例如咪唑并[4,5-c]喹啉,6,7,8,9-四氢咪唑并[4,5-c]喹啉,咪唑并[ 4,5-c]萘啶,6,7,8,9-四氢咪唑并[4,5-c]萘啶和咪唑并[4,5-c]吡啶),其中-CH(-R 2) 在咪唑环的1位上的稠合环中的咪唑环的2-位的稠合环中的-CH 2 - (CH 2 - ) - 基团和-CH(-R 1) 公开了含有化合物的药物组合物,制备该化合物的方法,以及这些化合物用作免疫调节剂的方法,用于诱导动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病。

    6,11-bridged erythromycin derivatives
    7.
    发明授权
    6,11-bridged erythromycin derivatives 有权
    6,11桥梁红霉素衍生物

    公开(公告)号:US6046171A

    公开(公告)日:2000-04-04

    申请号:US158459

    申请日:1998-09-22

    IPC分类号: C07H17/08 A61K31/70 C07H1/00

    CPC分类号: C07H17/08

    摘要: Novel 6,11-bridged erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.

    摘要翻译: 具有抗细菌活性的新型6,11-桥接的红霉素化合物及其药学上可接受的盐和酯,其组成包括治疗有效量的本发明化合物与药学上可接受的载体的组合,通过给予 哺乳动物含有治疗有效量的本发明化合物的药物组合物及其制备方法。

    Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
    8.
    发明申请
    Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds 失效
    哌嗪,[1,4]二氮杂环庚烷,[1,4]二氮杂环辛烷和[1,5]二氮辛烷稠合咪唑环化合物

    公开(公告)号:US20070167476A1

    公开(公告)日:2007-07-19

    申请号:US10596895

    申请日:2004-12-22

    IPC分类号: A61K31/4745 C07D487/22

    CPC分类号: C07D471/14 C07D471/04

    摘要: Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds (i.e., imidazoquinolines, tetrahydroimidazoquinolines, imidazonaphthyridines, tetrahydroimidazonaphthyridines, and imidazopyridines), pharmaceutical compositions containing the compounds, intermediates, methods of making, and methods of use of these compounds as immunomodulators, for inducing or inhibiting cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

    摘要翻译: 哌嗪,[1,4]二氮杂环庚烷,[1,4]二氮杂环辛烷和[1,5]二氮辛烷稠合的咪唑环化合物(即咪唑并喹啉,四氢咪唑并喹啉,咪唑并噻嗪,四氢咪唑并萘啶和咪唑并吡啶) 公开了制备方法以及这些化合物作为免疫调节剂用于诱导或抑制动物细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病的方法。

    1-Amino 1H-imidazoquinolines
    9.
    发明申请
    1-Amino 1H-imidazoquinolines 失效
    1-氨基-1H-咪唑并喹啉

    公开(公告)号:US20050054640A1

    公开(公告)日:2005-03-10

    申请号:US10933658

    申请日:2004-09-03

    CPC分类号: C07D471/02

    摘要: 1-Amino 1H-imidazoquinoline compounds, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.

    摘要翻译: 公开了1-氨基-1H-咪唑并喹啉化合物,含有这些化合物的药物组合物,中间体和制备方法以及这些化合物作为免疫调节剂的用途,用于调节动物中的细胞因子生物合成和治疗包括病毒和肿瘤疾病在内的疾病。